Skip to content
ClinCalc Pro
Menu
Topical otic steroid + antibiotic combination

Hydrocortisone with neomycin and polymyxin B

Brand names: Otosporin

A compound topical preparation combining the corticosteroid hydrocortisone with the antibiotics neomycin and polymyxin B sulfate, used for infected inflammatory conditions of the ear or eye.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Neomycin (an aminoglycoside) and polymyxin B provide complementary antibacterial cover against Gram-positive and Gram-negative organisms, while hydrocortisone reduces local inflammation.

Prescribing in practice

  • Avoid use in the ear when the tympanic membrane is perforated, as topical neomycin (an aminoglycoside) carries a risk of ototoxicity in the middle ear.
  • Neomycin is a common contact sensitiser, so discontinue if local hypersensitivity develops.
  • Reserve for short courses and reassess if there is no improvement to limit sensitisation and superinfection.

Monitoring

Monitor for clinical improvement and for any local hypersensitivity or, with ear use, hearing disturbance during treatment.

Counselling the patient

  • Use only at the affected site and complete the short course as directed.
  • Stop and seek advice if you develop a rash, itching or, with ear use, hearing changes or dizziness.
  • Tell the clinician if your eardrum may be perforated before using drops in the ear.

Evidence & guidelines

Combined antibiotic-corticosteroid topical preparations are established for infected otitis externa and external eye infection, used cautiously per UK guidance.

Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.